- Home
- Equipment
- usa new york
- inflammatory effect
Show results for
Refine by
Inflammatory Effect Equipment Supplied In Usa New York
6 equipment items found
Manufactured by:Cutting Edge Laser Technologies based inRochester, NEW YORK (USA)
In this model, MLS sources have a peak power of 75 W and an average power of up to 1.2 W delivered with the synchronization of emissions (continuous/chopped and pulsed), which enables the user to reach desired tissue depth, while ensuring complete safety against collateral tissue (heat) damage. Thanks to the higher peak power, one may act on the source of pain more directly by increasing the ...
Manufactured by:Cutting Edge Laser Technologies based inRochester, NEW YORK (USA)
The M-VET Therapy Laser is a result of the scientific and technological know-how of over thirty years of research and development in a new generation of therapeutic devices entirely dedicated to animal health. The benefits of the MLS synchronized pulse pattern are now enhanced through an optical fibre technology, which allows conveying higher intensity energy packets inside the tissues, in total ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
The emerging global threat from COVID-19 demanded immediate action. With cases rising rapidly, we set up a specialist team to use our AI-drug discovery platform to search for existing drugs — already proven safe — that could be repurposed to treat the virus. We are the only AI company to successfully identify a drug to treat COVID-19. Together by building bespoke drug repurposing ...
Manufactured by:Lifeasible based in, NEW YORK (USA)
Paeoniflorin has anti-myocardial ischemia, anticoagulation and inhibition of platelet aggregation, spasmolysis, analgesic and sedative effects. Anti-inflammatory and anti-ulcer effects; Liver protection; Regulating immune function and anti-hyperglycemia effect;Hypoxia ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-25-Osteo for spinal fusion is a proprietary Phase 3-ready product candidate. All doses of MPC-25-Osteo for the treatment of spinal fusion consist of 25 million MPCs delivered on a collagen ceramic carrier material into the disc space with stabilizing ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-06-ID is a Phase 3 product candidate for the treatment of chronic low back pain caused by disc degeneration (CLBP). It is being developed for patients who have exhausted conservative treatment options, may have failed epidural steroid injections and have no further treatment option other than invasive and costly surgical ...